Publication: Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.
| dc.contributor.author | Devesa, Ana | |
| dc.contributor.author | Fuster, Valentin | |
| dc.contributor.author | Vazirani, Ravi | |
| dc.contributor.author | Garcia-Lunar, Ines | |
| dc.contributor.author | Oliva, Belen | |
| dc.contributor.author | Espana, Samuel | |
| dc.contributor.author | Moreno-Arciniegas, Andrea | |
| dc.contributor.author | Sanz, Javier | |
| dc.contributor.author | Perez-Herreras, Cristina | |
| dc.contributor.author | Bueno, Hector | |
| dc.contributor.author | Lara-Pezzi, Enrique | |
| dc.contributor.author | Garcia-Alvarez, Ana | |
| dc.contributor.author | de Vega, Vicente Martínez | |
| dc.contributor.author | Fernandez-Friera, Leticia | |
| dc.contributor.author | Trivieri, Maria G | |
| dc.contributor.author | Fernandez-Ortiz, Antonio | |
| dc.contributor.author | Rossello, Xavier | |
| dc.contributor.author | Sanchez-Gonzalez, Javier | |
| dc.contributor.author | Ibáñez, Borja | |
| dc.contributor.funder | Centro Nacional de Investigaciones Cardiovasculares Carlos III (España) | es_ES |
| dc.contributor.funder | Banco Santander | es_ES |
| dc.contributor.funder | Unión Europea. Comisión Europea | es_ES |
| dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | es_ES |
| dc.contributor.funder | Comunidad de Madrid (España) | es_ES |
| dc.contributor.funder | Fundación La Caixa | es_ES |
| dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
| dc.contributor.funder | Fundación ProCNIC | es_ES |
| dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | es_ES |
| dc.date.accessioned | 2023-11-22T09:26:04Z | |
| dc.date.available | 2023-11-22T09:26:04Z | |
| dc.date.issued | 2023-11-01 | |
| dc.description.abstract | OBJECTIVE Experimental evidence suggests that metabolic syndrome (MetS) is associated with changes in cardiac metabolism. Whether this association occurs in humans is unknown. RESEARCH DESIGN AND METHODS 821 asymptomatic individuals from the Progression of Early Subclinical Atherosclerosis (PESA) study (50.6 [46.9-53.6] years, 83.7% male) underwent two whole-body 18F-fluorodeoxyglucose positron emission tomography-magnetic resonance (18F-FDG PET-MR) 4.8 ± 0.6 years apart. Presence of myocardial 18F-FDG uptake was evaluated qualitatively and quantitatively. No myocardial uptake was grade 0, while positive uptake was classified in grades 1-3 according to target-to-background ratio tertiles. RESULTS One hundred fifty-six participants (19.0%) showed no myocardial 18F-FDG uptake, and this was significantly associated with higher prevalence of MetS (29.0% vs. 13.9%, P < 0.001), hypertension (29.0% vs. 18.0%, P = 0.002), and diabetes (11.0% vs. 3.2%, P < 0.001), and with higher insulin resistance index (HOMA-IR, 1.64% vs. 1.23%, P < 0.001). Absence of myocardial uptake was associated with higher prevalence of early atherosclerosis (i.e., arterial 18F-FDG uptake, P = 0.004). On follow-up, the associations between myocardial 18F-FDG uptake and risk factors were replicated, and MetS was more frequent in the group without myocardial uptake. The increase in HOMA-IR was associated with a progressive decrease in myocardial uptake (P < 0.001). In 82% of subjects, the categorization according to presence/absence of myocardial 18F-FDG uptake did not change between baseline and follow-up. MetS regression on follow-up was associated with a significant (P < 0.001) increase in myocardial uptake. CONCLUSIONS Apparently healthy individuals without cardiac 18F-FDG uptake have higher HOMA-IR and higher prevalence of MetS traits, cardiovascular risk factors, and early atherosclerosis. An improvement in cardiometabolic profile is associated with the recovery of myocardial 18F-FDG uptake at follow-up. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | The PESA study is funded by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Santander Bank. B.I. is supported by the European Commission (grant numbers 819775 and 945118), by the Spanish Ministry of Science and Innovation (PID2019- 110369RB-I00), and by the Red Madrilena de ~ Nanomedicina en Imagen Molecular-Comunidad de Madrid (S2017/BMD-3867 RENIM-CM). A.D. is an Alfonso Martin Escudero fellow and is scientifically supported by La Caixa Foundation. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovacion (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/ 10.13039/501100011033). | es_ES |
| dc.format.number | 11 | es_ES |
| dc.format.page | 2050 | es_ES |
| dc.format.volume | 46 | es_ES |
| dc.identifier.citation | Diabetes Care. 2023 Nov 1;46(11):2050-2057. | es_ES |
| dc.identifier.doi | 10.2337/dc23-0871 | es_ES |
| dc.identifier.e-issn | 1935-5548 | es_ES |
| dc.identifier.journal | Diabetes care | es_ES |
| dc.identifier.pubmedID | 37713581 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/16709 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Diabetes Association (ADA) | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-110369RB-I00 | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/S2017/BMD-3867/RENIM-CM | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CEX2020-001041-S | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/819775 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/945118 | es_ES |
| dc.relation.publisherversion | 10.2337/dc23-0871 | es_ES |
| dc.repisalud.institucion | CNIC | es_ES |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovascular | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | Metabolic Syndrome | es_ES |
| dc.subject.mesh | Insulin Resistance | es_ES |
| dc.subject.mesh | Atherosclerosis | es_ES |
| dc.subject.mesh | Male | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Female | es_ES |
| dc.subject.mesh | Fluorodeoxyglucose F18 | es_ES |
| dc.subject.mesh | Heart | es_ES |
| dc.subject.mesh | Positron-Emission Tomography | es_ES |
| dc.subject.mesh | Radiopharmaceuticals | es_ES |
| dc.title | Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 558474d4-85be-4127-bda8-59128f707249 | |
| relation.isAuthorOfPublication | de903570-4c8c-4bcb-8cfe-d077154694e0 | |
| relation.isAuthorOfPublication | 2cac2b58-fa25-494c-92c5-5ac91f3d2036 | |
| relation.isAuthorOfPublication | aa5c6326-5e02-4c53-afad-fdf9c0115861 | |
| relation.isAuthorOfPublication | 465de6aa-7383-4ba5-b278-765f894f2c87 | |
| relation.isAuthorOfPublication | 4e417023-fc1f-41d2-8130-485f76466465 | |
| relation.isAuthorOfPublication | e7d4df9b-2306-4955-ba22-17d066e07612 | |
| relation.isAuthorOfPublication | 92018446-2b00-4798-a27d-d2b26871b81b | |
| relation.isAuthorOfPublication | 4b2a0672-e9a0-4788-b256-d3170c84aab2 | |
| relation.isAuthorOfPublication | c247543c-ab71-441c-8eec-b54f56c6a1ff | |
| relation.isAuthorOfPublication | bbc835c4-284a-4845-8a6e-adf765b43cc1 | |
| relation.isAuthorOfPublication | b6428aa3-d242-4efb-a7a2-b977c3aeadd8 | |
| relation.isAuthorOfPublication | 2cac8bb6-2bff-4bf6-8209-bdbd21781786 | |
| relation.isAuthorOfPublication.latestForDiscovery | 558474d4-85be-4127-bda8-59128f707249 |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- Supplemental_material_Cardiac Insulin Resistance_Diabetes Care_2023.pdf
- Size:
- 510.09 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo
Loading...
- Name:
- Cardiac Insulin Resistance_Diabetes Care_2023_1.pdf
- Size:
- 19.47 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo


